Vivo Acquires Infusion Associates to Increase Outpatient Companies
Vivo Infusion has introduced the acquisition of Infusion Associates, considerably increasing its operational footprint within the US.
The businesses didn’t disclose monetary particulars of the transaction.
As a part of this acquisition, Vivo Infusion will likely be liable for overseeing roughly 80 ambulatory infusion facilities throughout 15 states within the U.S.
Based in 2001, Infusion Associates grew by way of the opening of recent facilities and strategic acquisitions, primarily within the Midwest.
There are facilities in a number of US states, together with Michigan, Ohio, Minnesota and Wisconsin.
Infusion Associates has developed a singular enterprise mannequin that features doctor partnerships and a medical analysis division, enhancing the service providing for sufferers, pharmaceutical companions and payers.
Entry probably the most complete firm profiles in the marketplace, powered by GlobalData. Save hours of analysis. Acquire a aggressive edge.
Firm Profile – Free Pattern
Your obtain e-mail will arrive shortly
We’re satisfied of the distinctive high quality of our firm profiles. Nonetheless, we wish you to take advantage of helpful resolution in your firm, so we provide a free pattern which you can obtain by submitting the shape beneath
By GlobalData
Following the acquisition, Vivo Infusion plans to additional broaden within the US Midwest, with plans for extra new facilities.
Vivo Infusion CEO Chris Reef stated, “Infusion Associates brings a number of distinctive capabilities to Vivo’s rising enterprise that can proceed to strengthen {our relationships} with our sufferers, payers and pharmaceutical companions. We’re excited to collaborate with all the group.”
Since 2021, InTandem Capital Companions, a non-public fairness agency specialised in healthcare providers, has been a capital accomplice and main investor in Vivo Infusion.
Relating to the acquisition of Infusion Associates, Vivo Infusion reported that InTandem has obtained practically $150 million in further fairness from its restricted companions.
This funding is meant to help Vivo Infusion’s progress technique throughout the nation for the rest of the present yr and past.
TripleTree acted as unique monetary advisor to Infusion Associates on the most recent deal.
